Aduro Biotech (ADRO) IPO Opens Up 88%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
Aduro Biotech (ADRO) Sees IPO Price of $17/Share
April 14, 2015 10:13 AM EDTAduro Biotech, Inc. (Nasdaq: ADRO) filed an amended registration with the U.S. SEC for an IPO of its Common Stock. The company plans to offer 7 million common shares and sees an offering price of $17 per share. The company plans to list on... More



